iShares U.S. Healthcare ETF

IYH
$66.24 -0.39 (-0.59%)
Dividend Yield 1.17%
Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
December 19, 2025$0.252025-12-162025-12-16
September 19, 2025$0.192025-09-162025-09-16
June 20, 2025$0.172025-06-162025-06-16
March 21, 2025$0.162025-03-182025-03-18
December 20, 2024$0.202024-12-172024-12-17

Dividends Summary

Company News

ETFs to Secure Your Portfolio Amid Uncertain Market Conditions
Zacks Investment Research • N/A • August 8, 2024

Economists have raised the probability of a U.S. recession within the next 12 months, citing a disappointing jobs report and market volatility. However, JPMorgan Chase CEO Jamie Dimon believes the U.S. economy has not entered a recession, though the odds of one are more likely than not. Investors are advised to consider defensive sectors like qua...

What Lies in Store for Healthcare ETFs in Q2 Earnings? - Zacks Investment Research
Zacks Investment Research • Zacks Investment Research • July 24, 2024

The healthcare sector has gained momentum recently, with investors rushing to buy beaten-down stocks. The performance of major healthcare ETFs like XLV, VHT, IYH, and FHLC will depend on the upcoming earnings releases of big names like Pfizer, Merck, Amgen, AbbVie, Bristol Myers Squibb, and Eli Lilly.

Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy
The Motley Fool [email protected] (Katie Brockman) • June 22, 2024

You don't need to be a stock market expert to earn above-average returns.

Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
Zacks Investment Research • Zacks Equity Research • May 30, 2024

Sector ETF report for IYH

ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
Zacks Investment Research • Sweta Killa • May 1, 2024

Eli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro.

Related Companies